BioSpace News Archive

HPC Systems Inc., launched Science Cloud with Arm HPC. With this ARM-based Science Cloud, our customers including the scientists and engineers in many fields can have an alternative platform choice for their researches and applications that can be more efficient, better performance per watt and per dollar, and reduced TCO.

Dr. Dipnarine Maharaj was honored to be invited to present the keynote presentation at this year’s SEMAL Congress.

Beginning January 1, 2019, Cherokee County Board of Commissioners (the “County”) will provide its employees and their covered family members with access to Employer Direct Healthcare’s SurgeryPlus®, a supplemental benefit for non-emergent surgeries that provides high quality care, a better experience and lower costs.

Veterinary and Pediatric Researchers Forge Alliances

Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, today announced enrollment of the first U.S. patient in the Stellarex ILLUMENATE Below-the-Knee (BTK) Investigational Device Exemption (IDE) study, led by principal investigators Dr. Bill Gray and Dr. Mahmood K. Razavi.

The LexisNexis® Risk Solutions healthcare business has identified the breast cancer treatment facilities in the U.S. with the highest patient volumes, based on its analysis of annual patient volume data ending in June 2018.

The American College of Chest Physicians® (CHEST) announced today that Robert A. Musacchio, PhD, has been appointed as its new Executive Vice President and CEO, effective immediately.

A white paper written by Crohn’s & Colitis Foundation scientific advisors and staff examining the clinical, scientific, and regulatory landscape as it pertains to the use of medical cannabis in the treatment of Crohn’s disease and ulcerative colitis was recently published online by Inflammatory Bowel Diseases.

Metrics Contract Services is pleased to announce successful qualification of two commercial bottling lines for serialization at its new US$80 million oral solid dose commercial manufacturing site in Greenville, North Carolina, USA.

Urovant Sciences Ltd. today reported financial results for the three and six months ended September 30, 2018 and announced corporate updates.